Trueblood Wealth Management’s Cintas CTAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$755K Sell
4,440
-1,901
-30% -$329K 0.26% 119
2026
Q1
$1.07M Buy
6,341
+190
+3% +$36.4K 0.42% 77
2025
Q4
$1.16M Buy
6,151
+418
+7% +$78.7K 0.45% 71
2025
Q3
$1.18M Buy
5,733
+321
+6% +$68.6K 0.46% 74
2025
Q2
$1.21M Buy
5,412
+337
+7% +$72.5K 0.5% 63
2025
Q1
$1.04M Buy
5,075
+1,142
+29% +$227K 0.48% 70
2024
Q4
$719K Buy
3,933
+543
+16% +$114K 0.35% 98
2024
Q3
$698K Buy
3,390
+714
+27% +$138K 0.35% 93
2024
Q2
$468K Buy
2,676
+496
+23% +$84.7K 0.26% 114
2024
Q1
$374K Buy
+2,180
New +$336K 0.21% 134

Other funds holding CTAS

Trueblood Wealth Management's CTAS Position: Q2 2026 in Review

Trueblood Wealth Management reduced its Cintas (CTAS) stake by 30% in Q2 2026, selling an estimated $329K and leaving 4,440 shares worth $755K. The position accounts for 0.26% of the portfolio, ranked #119.

Trueblood Wealth Management first reported a position in CTAS in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.21M in Q2 2025. 1,422 funds tracked by Wall St. Rank hold CTAS as of Q2 2026.

  • Trueblood Wealth Management held 4,440 shares of Cintas worth $755K as of Q2 2026.
  • Trueblood Wealth Management sold 1,901 Cintas shares in Q2 2026, an estimated $329K.
  • Cintas made up 0.26% of Trueblood Wealth Management's portfolio in Q2 2026, its #119 holding.
  • Trueblood Wealth Management first reported a position in Cintas in Q1 2024 and has held it in 10 quarters since.
  • Trueblood Wealth Management's Cintas position peaked at $1.21M in Q2 2025.
  • 1,422 funds tracked by Wall St. Rank held Cintas as of Q2 2026.

Based on Trueblood Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.